VettaFi Weight Loss Drug & Treatment Index

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
As of May 02, 2022

Overview

An index of global companies manufacturers in the GLP-1 pharmaceuticals business or who enable the business. The index allocates 70% of its weight to a Principal Manufacturers segment and 30% to an Enablers segment.
Asset class
Equity
Category
Thematic
Region
Global
Rebalance frequency
Quarterly

Tickers

Price return
THINR
Total return
THINRT
Net total return
THINRN

Characteristics

Number of constituents
29
Market capitalization
$2.56 Trillon
Adjusted market capitalization
$2.43 Trillon
Dividend yield
1.51%

Resources

Composition

Top constituents

As of
December 3, 2024
Company Name
Company Name
Weight

10.8%

Company Name
Company Name
Weight

10.8%

Company Name
Company Name
Weight

10.8%

Company Name
Company Name
Weight

10.8%

Company Name
Company Name
Weight

10.8%

Company Name
Company Name
Weight

10.8%

Company Name
Company Name
Weight

10.8%

Company Name
Company Name
Weight

10.8%

Company Name
Company Name
Weight

10.8%

Company Name
Company Name
Weight

10.8%

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Linked products

Product name
Amplify Weight Loss Drug & Treatment ETF
Licensee

Amplify

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Insights

Sign up for index updates to stay in the know.
By clicking submit, you’re opting into communications, subject to our Privacy Policy.
By clicking submit, you’re opting into communications, subject to our Privacy Policy.

Interested in market data packages?

Contact our team for more information.
By clicking submit, you’re opting into communications, subject to our Privacy Policy.